Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial

Fig. 1

Percentage of patients with cardiometabolic parameters at target among (a) BMI and (b) WC categories. Statistics. p values of BMI or WC vs. factors were calculated using Chi square test.***p < 0.0001; **p < 0.001; *p < 0.01. ATPIII, adult treatment panel III criteria; BMI, body mass index; BP, blood pressure; HbA1c, glycated haemoglobin; HDL-C, high-density lipoprotein cholesterol; IISHMS, International Joint Interim Statement for the Harmonization of the Metabolic Syndrome criteria; LDL-C, low-density lipoprotein cholesterol; OADs, oral antihyperglycaemic drugs; TG, triglycerides; WC, waist circumference

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840